{
  "trial_id": "NCT01575652",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "chronic peritoneal dialysis",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "18-55 years",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "no antihypertensive drug usage prior 12 months",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "history of malignant hypertension or hypertensive encephalopathy or cerebrovascular accident within the 6 months prior to the study",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "chronic liver diseases, and recent acute illness and/or history of any overt chronic inflammatory disease",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has Wilson disease confirmed by high liver copper concentration. He is on standard CAPD program.",
  "_meta": {
    "topic_id": "55",
    "trial_id": "NCT01575652",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}